Derek M Meisner
General Counsel at Acumen Pharmaceuticals, Inc. (ABOS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $249K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 10SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 2,090173,999 held (−1%) | $3.26 | $7K | -34.4% |
| Mar 3SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 9,406173,999 held (−5%) | $3.01 | $28K | -28.9% |
| Jan 28SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 15,085173,999 held (−8%) | $3.00 | $45K | -28.7% |
| Jan 28SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 2,671173,999 held (−2%) | $3.00 | $8K | -28.7% |
| Jan 23SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 2,247180,686 held (−1%) | $1.81 | $4K | +18.2% |
| Jan 23SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 1,054179,632 held (−1%) | $1.84 | $2K | +16.3% |
| Jan 23SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 5,633173,999 held (−3%) | $1.90 | $11K | +12.6% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 6,819127,640 held (−5%) | $1.82 | $12K | +17.6% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 30,09297,548 held (−24%) | $1.82 | $55K | +17.6% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 5,20092,348 held (−5%) | $1.76 | $9K | +21.6% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 8,54883,800 held (−9%) | $1.71 | $15K | +25.1% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 4,000157,127 held (−2%) | $1.96 | $8K | +9.2% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 7,097150,030 held (−5%) | $1.97 | $14K | +8.6% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 3,801146,229 held (−3%) | $1.97 | $7K | +8.6% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 1,700144,529 held (−1%) | $1.99 | $3K | +7.5% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 10,070134,459 held (−7%) | $1.99 | $20K | +7.5% |
- Sell
General Counsel Derek M Meisner sold $7K of ABOS at $3.26 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Derek M Meisner sold $28K of ABOS at $3.01 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Derek M Meisner sold $45K of ABOS at $3.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Derek M Meisner sold $8K of ABOS at $3.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Derek M Meisner sold $4K of ABOS at $1.81 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Derek M Meisner sold $2K of ABOS at $1.84 — pre-scheduled 10b5-1 plan sale.